US alerted to "growing threat" of dengue fever
This article was originally published in Clinica
Executive Summary
The US National Institute of Allergy and Infectious Diseases (NIAID) are pouring money into research for diagnostics, vaccines and therapeutics to tackle dengue fever, which is being viewed as a growing threat to US citizens. Early diagnosis and treatment of dengue fever are critical to preventing shock and death, the NIAID says, and it sees the expansion of the medical armoury against the virus as a top priority.
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.